BCDA - BioCardia, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
27.78M
Enterprise Value 3
19.99M
Trailing P/E
N/A
Forward P/E 1
-4.28
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
46.45
Price/Book (mrq)
5.35
Enterprise Value/Revenue 3
33.43
Enterprise Value/EBITDA 6
-1.40

Trading Information

Stock Price History

Beta (5Y Monthly) 2.99
52-Week Change 3-72.39%
S&P500 52-Week Change 321.87%
52 Week High 320.7900
52 Week Low 33.1500
50-Day Moving Average 34.0823
200-Day Moving Average 36.4987

Share Statistics

Avg Vol (3 month) 332.57k
Avg Vol (10 day) 311.2k
Shares Outstanding 56.83M
Float 2.12M
% Held by Insiders 167.63%
% Held by Institutions 10.11%
Shares Short (Nov 29, 2019) 435.42k
Short Ratio (Nov 29, 2019) 42.4
Short % of Float (Nov 29, 2019) 41.07%
Short % of Shares Outstanding (Nov 29, 2019) 40.52%
Shares Short (prior month Oct 31, 2019) 425.37k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 29/1
Last Split Date 3Jun 6, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,397.66%

Management Effectiveness

Return on Assets (ttm)-110.38%
Return on Equity (ttm)-364.95%

Income Statement

Revenue (ttm)598k
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)131.00%
Gross Profit (ttm)-8.35M
EBITDA -14.24M
Net Income Avi to Common (ttm)-14.85M
Diluted EPS (ttm)-2.9560
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.91M
Total Cash Per Share (mrq)1.3
Total Debt (mrq)1.26M
Total Debt/Equity (mrq)24.26
Current Ratio (mrq)2.28
Book Value Per Share (mrq)0.76

Cash Flow Statement

Operating Cash Flow (ttm)-9.44M
Levered Free Cash Flow (ttm)-4.62M